相关实验视频

Updated: Sep 13, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

在KIRC中用于预后和治疗评估的线粒细胞相关基因签名

Dengyi Duan¹, Yangyang Guo¹, Jianmin Li²

¹Department of Radiology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.

Scientific reports

|July 27, 2025

概括

研究人员开发了一种新模型,使用与菌相关的基因来预测清细胞细胞癌 (KIRC) 的预后和治疗反应. 高风险患者表现出更好的免疫治疗结果,有助于个性化KIRC治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

清细胞细胞癌 (KIRC) 是一个重大的健康问题.
准确的预后标志物和KIRC的治疗策略对于患者的治疗结果至关重要.
线性菌是一种选择性自菌形式,在细胞平衡和疾病发病过程中发挥作用.

研究的目的:

在KIRC.中调查与线粒相关基因 (MRG) 的预后价值.
开发和验证KIRC预后和治疗反应的预测模型.
探索KIRC.内的免疫特征和潜在的治疗点.

主要方法:

使用 LASSO 考克斯回归分析系统识别MRG.
使用内部和外部KIRC队列开发和验证预后风险分层模型.
构建一个整合临床参数风险评分和临床参数的nomogram.
瘤微环境的表征和体外功能测定 (例如,METTL24过度表达).

主要成果:

建立并验证了基于MRG的强有力的预后风险模型.
高风险的KIRC患者表现出增强的免疫治疗反应.
发现METTL24过度表达抑制了KIRC细胞的增殖和迁移.
开发的诺米图允许对KIRC患者进行多维风险评估.

结论:

与菌相关的基因特征作为KIRC的新预后生物标志物.
这个签名为KIRC的个性化治疗策略和精准医学提供了宝贵的见解.
这些发现支持风险模型对治疗选择和改善患者结果的临床实用性.

关键词:

免疫微环境是一个微环境.免疫治疗是一种免疫疗法.线粒细胞衰变 - - 线粒细胞衰变 (mitophagy) 是一种预测模型是一个预测模型.脏清晰细胞癌是什么?

更多相关视频

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

Published on: November 22, 2017

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...